Trial Search Results

Showing 1 - 4 of 4 trials – Showing only trials currently accepting patients

• BR55 in Characterization of Ovarian Lesions

  Stanford is currently accepting patients for this trial.

• Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer

  Stanford is currently accepting patients for this trial.

• A Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen (innovaTV 208)

  Stanford is currently accepting patients for this trial.

• RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

  Stanford is currently accepting patients for this trial.